Navigation Links
Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
Date:9/26/2007

ALEXANDRIA, Va., Sept. 26 /PRNewswire/ -- Oxford Finance Corporation, one of the nation's leading providers of senior debt to the life science community, today announced it has finalized a $7 million secured loan agreement with Othera Pharmaceuticals, Inc. The debt facility will be used to support Othera's goal to become a leading specialty pharmaceutical company focused on novel, patient-administered formulations for ophthalmology, oncology and inflammatory disease.

"This is one of several opportunities we've had to provide financing to Othera," said J. Alden Philbrick, president and chief executive officer of Oxford. "Our business relationship with Othera began with a $1 million equipment loan in 2004, and we continue to be proud to fuel their innovative small molecule development program."

"The additional financing provided by Oxford will be applied to ongoing research and development efforts for our ophthalmic lead compound, OT-551, which is currently in Phase 2 studies, and our new development program for OT- 304 in thrombosis, oncology and inflammatory disease," said Philip Heifetz, vice president of finance and business development for Othera. "Oxford has demonstrated a strong commitment to Othera, and we look forward to a long and expanded relationship as our products advance through our pipeline."

About Oxford Finance Corporation

Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, is a specialty finance firm providing senior secured loans to public and private life science companies worldwide. For nearly 20 years, Oxford has delivered flexible financing solutions to its clients, enabling them to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $600 million in loans, with lines of credit ranging from $100 thousand to $20 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California and Massachusetts. For more information, visit '/>"/>

SOURCE Oxford Finance Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Early Stage: Step 11 - Other forms of finance
2. Merge Healthcare hires new VP of finance
3. Joint Finance blocks Doyle ethanol measure
4. Third Wave shuffles finance, sales management
5. Finance Committee rejects extra tax on Internet buys
6. Two Milwaukee finance IT firms agree to exchange check images
7. An analysis of Wisconsins new venture capital and early stage finance programs
8. Trouble-shooting: Misincorporation or low fidelity
9. Roche Diagnostics Corporation
10. Roche Diagnostics Corporation
11. Promega Corporation: Wisconsins quiet innovator

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sin...provider of vaccines, announced today that it exec...inovac (Dalian) Vaccine,Technology Co., Ltd. (Sino...e,and commercialize human-use vaccines. Sinovac wi...loping and commercializing world-class vaccines; t...
(Date:11/25/2009)...AN DIEGO, Nov. 25 Ardea ... that Barry D. Quart, Pharm.D., president and chie...fray 21st Annual Health Care Conference. , ,Prese...t Annual Health Care Conference,Date: Tuesday...me,Location: The New York Palace Hotel, New York,...
(Date:11/24/2009)..., HOUSTON, Nov. 24 IES (...ectrical and communications systems and services f...ets, announced today that its commercial business ...orcon JV to install the electrical systems for the...ty at the U.S. Army Medical Research Institute of ...
(Date:11/24/2009)... The New York investment bank KTA Capit...as agreed an AU$6.7 mil convertible note private p...rivate placement was arranged by KTA Capital as Ne... New York (PRWEB) November 2...k KTA Capital, LLC ("KTA Capital") has a...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...any Licenses Septin-9 DNA Methylation Biomarker fr...gnostics,Incorporated (NYSE: DGX ), the leading p...ices, today announced that it has licensed rights ...from Epigenomics AG,(Frankfurt, Prime Standard: EC...lop a molecular-based laboratory test that can hel...
...YORK, Feb. 19 Cowen Group, Inc. (Nasdaq:,COWN) an...nced today that,Matthew Q. Reber has been hired as...r is based in Connecticut and rejoins founders Gre...the Managing Directors of CHRP,with whom he previo...oining CHRP, Mr. Reber worked at Accretive LLC, a ...
...ARBOR, Mich., Feb. 19 MichBio, the association fo... chairman and chief,executive officer of Allegan, ...or its April 22 Annual Meeting in Ann Arbor. Papa,...for Quality, Affordable Healthcare,Products.", Pa... chief executive,officer. He was elected to the co...
Other Biology Technology:Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 2Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 3Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 4Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 2MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop 2
(Date:11/26/2009)...itehead researchers have developed a new type of g... genes and proteins used by pathogens, according t... cultures genes are present in two copies: one inh...ne inactivation by mutation is therefore inefficie...d copy usually remains active and takes over. , ...
(Date:11/25/2009)...ch, may be used to boost resistance to, or slow, t... of Medicine researchers report in a study publish...ce . , Parkinson,s disease is caused by a degene...ain known as the substantia nigra, which is respon... of dopamine in late-stage Parkinson,s causes symp...
(Date:11/25/2009)...the linchpin of the environment, where atmosphere,...ny students see soil as "just dirt" a place to gr...s are challenged with the task of helping students...of soil in the environment. , A collaborative p...at University of Nebraska-Lincoln, Oregon State Un...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2National Alliance for Hispanic Health President and CEO Applauds House Action Calls on Senate to Pass Health Reform in 2009 60914 1National Alliance for Hispanic Health President and CEO Applauds House Action Calls on Senate to Pass Health Reform in 2009 60914 2PhRMA Statement on House Passage of Health Care Reform Bill 60912 1PhRMA Statement on House Passage of Health Care Reform Bill 60912 2PhRMA Statement on House Passage of Health Care Reform Bill 60912 3Stupak Amendment Passes in Final House Health Care Bill A First Step to Victory but Many Battles Ahead We Must Rejoice With Caution 60910 1
... CHICAGO -- A spinal cord injury often leads to pe...site of the injury because the damaged nerve fiber... the capacity to grow again, but dont because they...e injury. , Northwestern University researchers ...s the formation of scar tissue at the injury site ...
... This release is available in German . , , Hal... with nitrogen could be lowered in future. Soil sc... Research (UFZ) have developed a new mathematical ...ons for microbiological water treatment. Using the...tical model, which is the most accurate to date, c...
... The bombardier beetle is inspiring designers of e...rs to improve spray technologies, writes Andy McIn...f Swedish Biomimetics 3000 Ltd, in Aprils Physics ...frica and Asia, is remarkable in that it can fire ...edators such as birds and frogs. While the chemic...
Other Biology News:Promising new nanotechnology for spinal cord injury 2New formula for combating the greenhouse gas nitrous oxide 2New formula for combating the greenhouse gas nitrous oxide 3New formula for combating the greenhouse gas nitrous oxide 4The bombardier beetle, power venom and spray technologies 2
Equine TNF-alpha / TNFSF1A, Unconjugated from R&D Systems
...ng Checker Kits provide two highly efficient metho...formation without time-consuming plasmid preparati...I, all you need to do is to transfer partial colon...mation plates into the solutions provided by the k...
GRADIENT MAKER, 30 ML from GE Healthcare, formerly Amersham Biosciences
...and G. Butcher (1998). • The major histocompa...n the immunology area. There is great interest in ...n as antigen-presenting molecules. Many immunology...biochemical and genetic techniques in order to stu...
Biology Products: